Skip to main content

TRANSLOCACIONES CROMOSOMICAS Y MUTAGENESIS INDUCIDA POR ROTURAS DE DOBLE CADENA GENERADAS DURANTE LA EXPRESION GENICA

PID2019-105212GB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

TDP1 suppresses chromosomal translocations and cell death induced by abortive TOP1 activity during gene transcription

  • Rubio-Contreras, Diana
  • Gómez-Herreros, Fernando
© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/., DNA topoisomerase I (TOP1) removes torsional stress by transiently cutting one DNA strand. Such cuts are rejoined by TOP1 but can occasionally become abortive generating permanent protein-linked single strand breaks (SSBs). The repair of these breaks is initiated by tyrosyl-DNA phosphodiesterase 1 (TDP1), a conserved enzyme that unlinks the TOP1 peptide from the DNA break. Additionally, some of these SSBs can result in double strand breaks (DSBs) either during replication or by a poorly understood transcription-associated process. In this study, we identify these DSBs as a source of genome rearrangements, which are suppressed by TDP1. Intriguingly, we also provide a mechanistic explanation for the formation of chromosomal translocations unveiling an error-prone pathway that relies on the MRN complex and canonical non-homologous end-joining. Collectively, these data highlight the threat posed by TOP1-induced DSBs during transcription and demonstrate the importance of TDP1-dependent end-joining in protecting both gene transcription and genome stability., This publication is part of the project R + D + i PID2019-105212GB-I00 funded by MCIN/AEI/10.13039/501100011033 to F.G-H. We also acknowledge the Andalusian Regional Government [P20_00561, BIO-271 to F.G-H.]; D.R-C. is recipient of a predoctoral fellowship from University of Sevilla [VI PPIT-US]. Funding for open access charge: PID2019-105212GB-I00 funded by MCIN/AEI/10.13039/501100011033 (to F.G-H.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

EWS::FLI1-DHX9 interaction promotes Ewing sarcoma sensitivity to DNA topoisomerase 1 poisons by altering R-loop metabolism

  • Olmedo-Pelayo, Joaquín
  • Granado-Calle, Esperanza
  • Delgado-Bellido, Daniel
  • Lobo Selma, Laura
  • Jordán-Pérez, Carmen
  • Monteiro-Amaral, Ana T.
  • Ehlers, Anna C.
  • Ohmura, Shunya
  • García-Domínguez, Daniel
  • Mackintosh, Carlos
  • Carcaboso, Ángel M.
  • Alonso García de la Rosa, Francisco Javier
  • Machado, Isidro
  • Llombart-Bosch, A.
  • Scotlandi, Katia
  • Grünewald, Thomas G. P.
  • Gómez-Herreros, Fernando
  • Álava, Enrique de
Drug resistance is an ill-defined cause of dismal outcomes in cancer. Ewing sarcoma (EwS), a pediatric cancer characterized by high therapy failure rates, is driven by a single oncogenic event generating EWSR1::ETS gene fusions (primarily EWSR1::FLI1) in a silent genomic background. This provides a straightforward model to study the impact of gene fusions on drug responses. Here, we describe a novel mechanism of sensitivity to DNA topoisomerase 1 poisons in EwS. We discovered that EWS::FLI1 prevents the resolution of R-loops induced by these drugs via sequestering DHX9 helicase, ultimately resulting in R-loop accumulation, replication stress, and genome instability. In turn, excessive DHX9 or reduced EWS::FLI1 levels render EwS cells resistant to the active metabolite of irinotecan (SN-38) independent of proliferation and global transcription rates. This resistance helps explain how elevated DHX9 levels predict worse clinical outcomes. Overall, our research demonstrates the impact of a dominant mutation on cancer drug sensitivity, highlighting its significant clinical implications., JO-P is supported by Ph.D. grant Plan Propio from the University of Seville. DD-B is supported by Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (PAIDI 2020, POSTDOC_21_00865). DJG-D was supported by the VII Plan Propio de Investigación y Transferencia de la Universidad de Sevilla [Contrato de Acceso (II.4)/VII PPIT-US]. The laboratory of JA is supported by Instituto de Salud Carlos III (grant numbers PI20CIII/00020, DTS22CIII/00003, PMP21-00073); Asociación Pablo Ugarte (TRPV205/18, DGDO195722); Asociación Candela Riera, Asociación Todos Somos Iván & Fundación Sonrisa de Alex (TVP333-19, TVP-1324/15). The laboratory of TGPG is supported by grants from the Matthias-Lackas Foundation, the Dr. Leopold und Carmen Ellinger Foundation, the Deutsche Forschungsgemeinschaft (DFG 458891500), the German Cancer Aid (DKH-7011411, DKH-70114278), the Boehringer-Ingelheim foundation, the Dr. Rolf M. Schwiete foundation, the SMARCB1 association, the Ministry of Education and Research (BMBF; SMART-CARE and HEROES-AYA) and the Barbara and Wilfried Mohr foundation. A.C.E. was supported by a scholarship from the German Cancer Aid. The laboratory of FG-H is supported by grants funded by MCIN/AEI/10.13039/501100011033/FEDER, UE (R + D + i PID2019-105212GB-I00 and PID2022-137143NB-I00) and the Andalusian Regional Government: Fondo Europeo de Desarrollo Regional (FEDER) y Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía (P20_00561) to FG-H. The laboratory of EdA is supported by grants from ISCIII-FEDER (PI20/00003, PI23/1460 and PMP22/00054), Consejería de Salud y Consumo, Junta de Andalucía (PE-0186-2018, PI-0061-2020), Fundación Científica AECC (ECAEC222952DEAL), Fundación CRIS Contra el Cáncer, Asociación Pablo Ugarte, Fundación María García Estrada, and CIBERONC Instituto de Salud Carlos III, CB16/12/00361., Peer reviewed